{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:29:51Z","timestamp":1790616591045,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR8251\/MED\/31\/281\/2013"],"award-info":[{"award-number":["BT\/PR8251\/MED\/31\/281\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000732","name":"UK-India Education and Research Initiative","doi-asserted-by":"publisher","award":["IND\/CONT\/E\/12\u201013\/793"],"award-info":[{"award-number":["IND\/CONT\/E\/12\u201013\/793"]}],"id":[{"id":"10.13039\/501100000732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Exogenous growth factor\u2010mobilized bone marrow (<jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content>) stem cells have shown a differential response in the management of decompensated cirrhosis (<jats:styled-content style=\"fixed-case\">DC<\/jats:styled-content>). This study was designed to evaluate potential clinical benefit of adding Erythropoietin (<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>) in granulocyte\u2010colony stimulating factor (G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content>)\u2010mobilized stem cell therapy, possible mechanisms of regeneration and predictive factors of regenerative response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixty consecutive <jats:styled-content style=\"fixed-case\">DC<\/jats:styled-content> patients received either G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content> (Group A; n\u00a0=\u00a030) or G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> and placebo (Group B; n\u00a0=\u00a030) for 2\u00a0months and were carefully followed up for 1\u00a0year. Baseline and post\u2010treatment liver biopsy, <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> biopsy and <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> aspirate were analysed for fibro\u2010inflammatory and regenerative response and <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> hematopoietic reservoir.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Addition of <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content> to G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> showed a significant improvement in Child\u2010Pugh score (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.03) and <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content> score (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.003) as compared to G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> alone, with reduction in mortality (16.6% vs 36.7%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.09). The combination arm also demonstrated a decreased incidence of acute kidney injury (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001), encephalopathy (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.005) and refilling of ascites (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.03). Compared to monotherapy, it increased <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>163+ macrophages (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.013), Ki67+ index (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001) with decrease in \u03b1\u2010<jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content> levels (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001) in liver tissue. The response was better with grade 1 and 2 than with grade 3 ascites; Child B cirrhosis and <jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>\u00a0&lt;\u00a016. Non\u2010responders had lower hematopoietic stem cells (<jats:styled-content style=\"fixed-case\">HSC<\/jats:styled-content>s) at baseline. On multivariate analysis, the liver disease severity (<jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>\u00a0&lt;\u00a016) and a relatively preserved <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HSC<\/jats:styled-content>s\u00a0&gt;\u00a00.4) predicted therapeutic response (<jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content>\u00a0=\u00a00.82).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Early DC (<jats:styled-content style=\"fixed-case\">MELD<\/jats:styled-content>\u00a0&lt;\u00a016) patients with mild\u2010moderate ascites and those with a healthy cellular baseline <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> respond better to growth factor therapy. Addition of <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content> to G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> provides better regenerative response than G\u2010<jats:styled-content style=\"fixed-case\">CSF<\/jats:styled-content> monotherapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.13923","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T06:48:54Z","timestamp":1530514134000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis"],"prefix":"10.1111","volume":"39","author":[{"given":"Lovkesh","family":"Anand","sequence":"first","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhagan","family":"Bihari","sequence":"additional","affiliation":[{"name":"Department of Pathology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan K.","family":"Kedarisetty","sequence":"additional","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetalnath B.","family":"Rooge","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Shubham","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrish","family":"Sahney","sequence":"additional","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-8334","authenticated-orcid":false,"given":"Manoj K.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5610","authenticated-orcid":false,"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[{"name":"Department of Hepatology Institute of Liver and Biliary Sciences  New Delhi India"},{"name":"Department of Molecular and Cellular Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12576"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.09.024"},{"issue":"2","key":"e_1_2_11_5_1","first-page":"CD002148","article-title":"Colchicine for alcoholic and non\u2010alcoholic liver fibrosis and cirrhosis","volume":"18","author":"Rambaldi A","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.027"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.054"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00912.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15994"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-57"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20822"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.02.018"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.154"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i7.1104"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30326-6"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50315"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301255"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-012-1291-2"},{"key":"e_1_2_11_20_1","first-page":"50","volume-title":"Surgery and Portal Hypertension","author":"Child C","year":"1964"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50016"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.102764"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01803.x"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12195"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3653"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66369"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0494fje"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21737"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02680001"},{"key":"e_1_2_11_30_1","first-page":"F838","article-title":"In vivo and in vitro pressor effects of erythropoietin in rats","volume":"269","author":"Vaziri ND","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05040908"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181492616"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28754"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:37:24Z","timestamp":1694821044000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/liv.13923"],"URL":"https:\/\/doi.org\/10.1111\/liv.13923","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]},"assertion":[{"value":"2017-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}